AAAAAA

   
Results: 1-7 |
Results: 7
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone
Authors: Chatzistamou, I Schally, AV Varga, JL Groot, K Busto, R Armatis, P Halmos, G
Citation: I. Chatzistamou et al., Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone, ANTI-CANC D, 12(9), 2001, pp. 761-768
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix
Authors: Chatzistamou, I Schally, AV Szepeshazi, K Groot, K Hebert, F Arencibia, JM
Citation: I. Chatzistamou et al., Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix, CANCER LETT, 171(1), 2001, pp. 37-45
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide
Authors: Chatzistamou, I Schally, AV Varga, JL Groot, K Armatis, P Bajo, AM
Citation: I. Chatzistamou et al., Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide, J CANC RES, 127(11), 2001, pp. 645-652
Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cellline xenografted into nude mice
Authors: Chatzistamou, I Schally, AV Varga, JL Groot, K Armatis, P Busto, R Halmos, G
Citation: I. Chatzistamou et al., Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cellline xenografted into nude mice, J CLIN END, 86(5), 2001, pp. 2144-2152
Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207
Authors: Chatzistamou, I Schally, AV Nagy, A Armatis, P Szepeshazi, K Halmos, G
Citation: I. Chatzistamou et al., Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207, CLIN CANC R, 6(10), 2000, pp. 4158-4165
Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice
Authors: Kahan, Z Varga, JL Schally, AV Rekasi, Z Armatis, P Chatzistamou, I Czompoly, T Halmos, G
Citation: Z. Kahan et al., Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice, BREAST CANC, 60(1), 2000, pp. 71-79
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-junand c-fos oncogene expression by bombesin antagonists
Authors: Chatzistamou, I Schally, AV Sun, B Armatis, P Szepeshazi, K
Citation: I. Chatzistamou et al., Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-junand c-fos oncogene expression by bombesin antagonists, BR J CANC, 83(7), 2000, pp. 906-913
Risultati: 1-7 |